University of West England Adopts HeartSciences' MyoVista Insights™ Platform and MyoVista wavECG™ Device to Establish ECG Education and Technology Reference Center

Southlake, TX — HeartSciences Inc. (Nasdaq: HSCS / HSCSW), a healthcare information technology (HIT) company advancing electrocardiography (ECG/EKG) through the integration of artificial intelligence (AI), today announced that the University of the West of England ("UWE") has adopted the Company's MyoVista Insights platform and MyoVista wavECG device as its exclusive ECG technologies to establish a Reference Center for ECG Education and Technology.

Under the agreement, MyoVista Insights and the MyoVista wavECG device will be used exclusively across UWE's cardiac and physiological science teaching programs to train the next generation of cardiac scientists. UWE is one of the UK's largest providers of Cardiac Healthcare Science and Physiological Science education, delivering a nationally aligned portfolio of programs that directly support NHS England workforce priorities and contribute meaningfully to the UK's cardiac diagnostic capacity.

The establishment of the UWE ECG Education and Technology Reference Center creates a nationally aligned academic reference site that supports future clinical adoption discussions with NHS trusts, provides real-world validation of MyoVista Insights in education and research settings, and strengthens HeartSciences' long-term commercial positioning within the UK healthcare ecosystem.

Duncan Sleeman, Senior Lecturer in Cardiac Physiology and Programme Lead (PGCert Echocardiography) at UWE, and Senior Practice Educator for Healthcare Sciences at NHS England Southwest, commented, "HeartSciences' MyoVista Insights platform represents a significant advance over traditional ECG systems. It enables students to move beyond paper-based pattern recognition and engage in detailed, quantitative ECG analysis, supporting a deeper understanding of cardiac electrophysiology and pathology. Even at this early stage of adoption, we are seeing clear benefits in student engagement, confidence, and diagnostic insight, alongside valuable opportunities for undergraduate and postgraduate research. This directly supports the development of a digitally literate, analytically skilled, and future-ready NHS cardiac diagnostic workforce."

Andrew Simpson, Chief Executive Officer of HeartSciences, added, "We are delighted that UWE has selected HeartSciences to establish an ECG Education and Technology Reference Center. Training the next generation of NHS cardiac scientists on MyoVista Insights not only reinforces the clinical and educational value of our platform but also creates a strategically important reference site that supports our broader commercial engagement with the NHS in the UK."